Estimating the Prevalence of Binge Eating Disorder in a Community Sample From the United States: Comparing DSM-IV-TR and DSM-5 Criteria
Estimating the Prevalence of Binge Eating Disorder in a Community Sample From the United States: Comparing DSM-IV-TR and DSM-5 Criteria
复制标题
DOI：
10.4088/jcp.15m10059
复制
发表时间：
2016-08-01
影响因子：
5.3
通讯作者：
Erder, M. Haim
中科院分区：
文献类型：
--
作者：
Cossrow, Nicole;Pawaskar, Manjiri;Erder, M. Haim
目的：估计暴食症（BED）的患病率根据DSM-5和DSM-IV-TR标准在美国成年人，并估计个人的比例符合DSM-5 BED标准谁报告被正式diagnosed.Methods：一个代表性的美国成年人参加了全国健康和健康调查的样本被要求回应互联网调查（在2013年10月进行）。评估包括基于DSM-5和DSM-IV-TR标准的3个月、12个月和终生BED患病率以及人口统计学、精神病合并症和自尊（Rosenberg自尊量表）。提供了描述性统计数据。患病率估计使用后分层抽样weights.Results计算：22,397受访者，344（女性，n = 242;男性，n = 102）自我报告的症状符合DSM-5床的症状标准。预计美国人群的3个月、12个月和终生DSM-5患病率估计值（95% CI）分别为1.19%（1.04%-1.37%）、1.64%（1.45%-1.85%）和2.03%（1.83%-2.26%）。12个月和终生DSM-IV-TR预测患病率估计值分别为1.15%（1.00%-1.32%）和1.52%（1.35%-1.70%）。在过去12个月内符合DSM-5 BED标准的受访者中，3.2%（11/344）报告接受了正式诊断。与非BED受访者相比，在过去12个月内符合DSM-5 BED标准的受访者更年轻（平均+/-SD年龄= 46.01 +/-14.32 vs 51.59 +/-15.80岁; P <.001），体重指数较高（平均值+/-SD = 33.71 +/-9.36 vs 27.96 +/-6.68 kg/m2; P <.001），并且自尊心较低（平均值+/-SD评分= 16.47 +/-6.99 vs 23.33 +/-6.06; P <0.001）。结论：DSM-5 BED标准导致比DSM-IV-TR标准更高的BED患病率估计。大多数BED受访者没有报告被正式诊断，表明BED识别和诊断的需求未得到满足。(C)版权所有2016 Physicians Postgraduate Press，Inc.
Objective: To estimate binge eating disorder (BED) prevalence according to DSM-5 and DSM-IV-TR criteria in US adults and to estimate the proportion of individuals meeting DSM-5 BED criteria who reported being formally diagnosed.Methods: A representative sample of US adults who participated in the National Health and Wellness Survey were asked to respond to an Internet survey (conducted in October 2013). Assessments included 3-month, 12-month, and lifetime BED prevalence based on DSM-5 and DSM-IV-TR criteria and demographics, psychiatric comorbidities, and self-esteem (Rosenberg Self-Esteem Scale). Descriptive statistics are provided. Prevalence estimates were calculated using poststratification sampling weights.Results: Of 22,397 respondents, 344 (women, n = 242; men, n = 102) self-reported symptoms consistent with DSM-5 BED symptom criteria. The 3-month, 12-month, and lifetime DSM-5 prevalence estimates (95% CIs) projected to the US population were 1.19% (1.04%-1.37%), 1.64% (1.45%-1.85%), and 2.03% (1.83%-2.26%), respectively. The 12-month and lifetime projected DSM-IV-TR prevalence estimates were 1.15% (1.00%-1.32%) and 1.52% (1.35%-1.70%), respectively. Of respondents meeting DSM-5 BED criteria in the past 12 months, 3.2% (11/344) reported receiving a formal diagnosis. Compared with non-BED respondents, respondents meeting DSM-5 BED criteria in the past 12 months were younger (mean +/- SD age = 46.01 +/- 14.32 vs 51.59 +/- 15.80 years; P < .001), had a higher body mass index (mean +/- SD = 33.71 +/- 9.36 vs 27.96 +/- 6.68 kg/m(2); P < .001), and had lower self-esteem (mean +/- SD score = 16.47 +/- 6.99 vs 23.33 +/- 6.06; P < .001).Conclusions: DSM-5 BED criteria resulted in higher BED prevalence estimates than with DSM-IV-TR criteria. Most BED respondents did not report being formally diagnosed, indicating an unmet need in BED recognition and diagnosis. (C) Copyright 2016 Physicians Postgraduate Press, Inc.